ACM
GILD icon

Allred Capital Management’s Gilead Sciences GILD Stock Holding History

Allred Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,329
Closed -$215K – 404
2021
Q1 		$215K Sell
3,329
-590
-15% -$38K 0.1% 172
2020
Q4 		$228K Buy
+3,919
New +$236K 0.12% 157
2020
Q1 		– Sell
-984
Closed -$63.9K – 349
2019
Q4 		$63.9K Buy
+984
New +$64.1K 0.03% 293

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Allred Capital Management's GILD Position: Q2 2021 in Review

Allred Capital Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 3,329 shares — an estimated $215K sold.

Allred Capital Management first reported a position in GILD in Q4 2019 and held it in 3 quarters. The position peaked at $228K in Q4 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Allred Capital Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Allred Capital Management sold 3,329 Gilead Sciences shares in Q2 2021, an estimated $215K.
  • Allred Capital Management first reported a position in Gilead Sciences in Q4 2019 and held it in 3 quarters.
  • Allred Capital Management's Gilead Sciences position peaked at $228K in Q4 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.